We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WSTN:NASDAQWestin Acquisition Corp Analysis

Data as of 2026-06-16 - not real-time

$10.08

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Westin Acquisition Corp trades at a price‑to‑book of 14.44×, far above typical SPAC valuations, while reporting zero revenue, margins and earnings since its 2025 inception. The technical picture shows a bullish alignment of the 20‑day, 50‑day and 200‑day SMAs, yet the RSI of 94.6 signals extreme overbought conditions and the MACD histogram has turned negative, delivering a bearish signal. Volume has been sharply declining, with an average three‑month volume of just over 5,300 shares and a current daily flow of only three shares, exposing a severe liquidity constraint. Volatility over the past 30 days is modest at about 1 %, and beta is virtually zero, indicating limited price sensitivity to broader market moves but also limited upside potential. The company’s balance sheet is heavily skewed, with a debt‑to‑equity ratio of 10.78, cash of only $361k against debt of $449 M, raising concerns about financial flexibility. Market sentiment is in the “Extreme Greed” zone (Fear & Greed Index 92.13), which may be inflating the price despite the lack of fundamental support. In summary, the stock is overvalued, illiquid, and carries high execution risk pending a merger or other business combination.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • RSI indicates imminent short‑term pullback
  • Bearish MACD histogram
  • Extremely low daily trading volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential de‑SPAC catalyst could unlock value
  • High debt‑to‑equity ratio limits financial flexibility
  • Current overvaluation relative to book value

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • No operating history or revenue generation
  • Sustained high leverage with minimal cash
  • Persistent overvaluation and liquidity constraints

Key Metrics & Analysis

Financial Health

Debt/Equity10.78
P/B Ratio14.4
Industry P/E17.1

Technical Analysis

TrendBullish
RSI94.6
Support$10.05
Resistance$10.10
MA 20$10.08
MA 50$10.04
MA 200$10.00
MACDBearish
VolumeDecreasing
Fear & Greed Index92.13

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.01
Volatility1.02%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.